Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar latinoeconomist (30.15) Submitted: 7/6/2011 5:20:26 PM : Outperform Start Price: $1.81 ALXA Score: -77.78

Great growth potential.

Featured Broker Partners


Advertisement